Our Company

Freespira, Inc. is the maker of Freespira, an at-home behavioral health treatment with FDA indications for PTSD and panic disorder symptoms. Freespira’s clinically-validated solution combines a medical device with high-touch support to deliver rapid and lasting symptom relief in just 28 days.

Health plans, providers, and self-insured employers use the company’s solutions to improve quality of life and to support the appropriate use of valuable healthcare resources.

Freespira Leadership Team

Joseph Perekupka

Chief Executive Officer

Simon Thomas

President

Robert Cuyler, PhD

Chief Clinical Officer

Camille McMullen

Senior Vice President, Government Relations

Sarah Koenig

Head of Brand and B2B Marketing

Michelle Russell

Vice President, Care Operations and Client Success

21689af1-74a7-4eb0-b2ce-be33393927a1 (1)

Katie Blair

Head of Member Engagement and Provider Marketing

Freespira’s breakthrough treatment for panic disorder and PTSD epitomizes the critical importance of innovation in healthcare – and the power of human-centered technology to make a difference in the lives of those who struggle with debilitating mental illnesses on a daily basis.

-Dr. Woodrow Myers

By helping the millions of Americans who suffer from panic disorder and PTSD find relief and stay out of the ER, Freespira can demonstrate significant ROI for employers and health plans.

-Steve Schwartz

Freespira is at the forefront of the tech-enabled behavioral health treatment space at an incredibly exciting time for health plans, employers, providers and patients, who now have more options than ever before for how, where, and when to access the mental health solutions that they want and deserve.

-Solome Tibebu